2025 Sponsors & Exhibitors

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing efficiency and reducing the barriers to participation for healthcare providers. Paradigm Health aims to break down barriers across the trial ecosystem through seamless infrastructure implemented at providers. For more information please visit https://www.paradigm.inc/

Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a 1,000 early-phase clinical trials, including for 45 therapies that were approved by the FDA or EMA. START represents the world’s largest roster of early-phase Principal Investigators (PIs) across its ten clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com.

N-Power Medicine is expanding access to oncology clinical trials across a network of community practices. N-Power Medicine provides clinical research infrastructure, including staff and technology, across all patients. This supports sites by standardizing high-quality data in a real-time registry at the point of care, facilitating patient identification and clinical trial conduct. For more information, go to https://www.npowermedicine.com/

SiteBridge, partnered with the American Medical Association's Health2047 venture studio, is an integrated research organization with a network of community practices to empower clinical trials in areas that are historically the most vulnerable and the hardest to reach. Our Trial In A Box™ brings the people, process, and technologies to support in the clinic, community, and patients' homes and enables real-world-data (RWD) solutions.

Triomics is a provider of a GenAI native cancer data platform. Utilizing their proprietary OncoLLM, a constellation of models and pipelines tailored specifically to the complexities of oncology, they are able to support mission critical tasks such as clinical trial matching, pre-charting and summarization, and data curation for tumor registries and RWE/RWD.

MRN is an innovative market-leader of patient-centric and site-centric solutions for efficient clinical trial delivery. Through our integrated in-home visit delivery and global site network of trained, research ready sites in new communities, all empowered by our digital trial solutions, we allow the medical research community to create more flexible, efficient, and accessible clinical trials. We customize our solutions to optimize each individual trial protocol and deliver accelerated timelines. By engaging patients and empowering research sites, we increase trial recruitment and enrollment rates, improve site participation and engagement, and improve patient retention around the world. For more information, go to https://themrn.io/.

Our network of treating physicians refer their protocol eligible, highly motivated patients directly to your sites.  Our model is entirely pay for performance.

Univo IRB is an independent IRB committed to making research more accessible, inclusive, and human. Through our OneVerse® platform, we deliver fast, friendly, and fair reviews with clear communication and responsive support. We simplify the research experience—empowering sponsors and sites while always prioritizing participant protection. For more information, go to https://www.univo-group.com

As a leading Integrated Research Organization (IRO), we partner with major healthcare systems to embed clinical trials at the point of care, connecting patients to research through physicians they already trust, in the communities they already love. Our model unlocks access to broader, more diverse populations, driving faster enrollment, stronger retention, and richer data. With centralized resources and streamlined operations, we accelerate study start-up and reduce friction across the research lifecycle. Because when research is integrated, healthcare is elevated.

Optum Life Sciences, part of UnitedHealth Group’s Innovation Platform, helps connect the life sciences industry to the broader healthcare ecosystem to catalyze innovation and impact. Our experienced consultants collaborate to solve tough questions and uncover new possibilities, helping improve patient outcomes. We analyze real-world data to address the needs of payers, providers, patients and regulators. For information about our end-to-end healthcare technologies, solutions and services, including real-world evidence generation and clinical trial solutions, visit www.optum.com/life-sciences.

RxE2 powers community-based clinical trials through technology that expands equitable access to research. By enabling community pharmacies to operate as next-generation clinical trial sites, we recruit, engage, and retain patients where they live and receive care, integrating pharmacists into research to accelerate enrollment, improve adherence, and deliver better outcomes. For more information, please visit https://rxe2.com/